0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blister-free Syringe Vaccine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-4J15563
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Blister free Syringe Vaccine Market Research Report 2023
BUY CHAPTERS

Global Blister-free Syringe Vaccine Market Research Report 2025

Code: QYRE-Auto-4J15563
Report
May 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blister-free Syringe Vaccine Market Size

The global market for Blister-free Syringe Vaccine was valued at US$ 5508 million in the year 2024 and is projected to reach a revised size of US$ 8673 million by 2031, growing at a CAGR of 6.8% during the forecast period.

Blister-free Syringe Vaccine Market

Blister-free Syringe Vaccine Market

A "blister-free syringe vaccine" typically refers to a type of syringe used for administering vaccines that is designed to minimize or eliminate the formation of air bubbles or blisters when the vaccine is drawn into the syringe. Air bubbles in a syringe can be problematic during vaccine administration because they can interfere with the accuracy of the dosage, potentially leading to under-dosing or over-dosing.
The blister-free syringe vaccine market is driven by the pressing need for efficient and safe vaccine delivery, especially in the context of mass vaccination campaigns, as it eliminates the risks associated with handling glass vials and can improve vaccination rates. These syringes are designed to provide a reliable and convenient method for administering vaccines without the risk of glass breakage and contamination. The ease of use, reduced vaccine wastage, and potential for self-administration further contribute to market growth. However, challenges exist, including the need for rigorous quality control and assurance to ensure the reliability and safety of these syringes. Cost considerations in resource-constrained healthcare settings may also pose challenges to widespread adoption. To thrive in this market, stakeholders must address these challenges while emphasizing the benefits of blister-free syringes in enhancing vaccination efficiency and safety, particularly during public health emergencies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blister-free Syringe Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blister-free Syringe Vaccine.
The Blister-free Syringe Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blister-free Syringe Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blister-free Syringe Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Blister-free Syringe Vaccine Market Report

Report Metric Details
Report Name Blister-free Syringe Vaccine Market
Accounted market size in year US$ 5508 million
Forecasted market size in 2031 US$ 8673 million
CAGR 6.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, GSK, Sanofi, CSL, Merck, KM Biologics, Viatris, AstraZeneca, Hualan Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Blister-free Syringe Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Blister-free Syringe Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Blister-free Syringe Vaccine Market growing?

Ans: The Blister-free Syringe Vaccine Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the Blister-free Syringe Vaccine Market size in 2031?

Ans: The Blister-free Syringe Vaccine Market size in 2031 will be US$ 8673 million.

Who are the main players in the Blister-free Syringe Vaccine Market report?

Ans: The main players in the Blister-free Syringe Vaccine Market are Pfizer, GSK, Sanofi, CSL, Merck, KM Biologics, Viatris, AstraZeneca, Hualan Bio

What are the Application segmentation covered in the Blister-free Syringe Vaccine Market report?

Ans: The Applications covered in the Blister-free Syringe Vaccine Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the Blister-free Syringe Vaccine Market report?

Ans: The Types covered in the Blister-free Syringe Vaccine Market report are Live Attenuated Vaccines, Inactivated Vaccines, mRNA Vaccine, DNA Recombination Vaccine, Other

Recommended Reports

Syringe & Ampoule Markets

Vaccine Packaging Devices

Vaccine Delivery & Types

1 Blister-free Syringe Vaccine Market Overview
1.1 Product Definition
1.2 Blister-free Syringe Vaccine by Type
1.2.1 Global Blister-free Syringe Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 mRNA Vaccine
1.2.5 DNA Recombination Vaccine
1.2.6 Other
1.3 Blister-free Syringe Vaccine by Application
1.3.1 Global Blister-free Syringe Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Global Blister-free Syringe Vaccine Market Size Estimates and Forecasts
1.4.1 Global Blister-free Syringe Vaccine Revenue 2020-2031
1.4.2 Global Blister-free Syringe Vaccine Sales 2020-2031
1.4.3 Global Blister-free Syringe Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Blister-free Syringe Vaccine Market Competition by Manufacturers
2.1 Global Blister-free Syringe Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Blister-free Syringe Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Blister-free Syringe Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Blister-free Syringe Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Blister-free Syringe Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blister-free Syringe Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Blister-free Syringe Vaccine, Date of Enter into This Industry
2.8 Global Blister-free Syringe Vaccine Market Competitive Situation and Trends
2.8.1 Global Blister-free Syringe Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Blister-free Syringe Vaccine Players Market Share by Revenue
2.8.3 Global Blister-free Syringe Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blister-free Syringe Vaccine Market Scenario by Region
3.1 Global Blister-free Syringe Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Blister-free Syringe Vaccine Sales by Region: 2020-2031
3.2.1 Global Blister-free Syringe Vaccine Sales by Region: 2020-2025
3.2.2 Global Blister-free Syringe Vaccine Sales by Region: 2026-2031
3.3 Global Blister-free Syringe Vaccine Revenue by Region: 2020-2031
3.3.1 Global Blister-free Syringe Vaccine Revenue by Region: 2020-2025
3.3.2 Global Blister-free Syringe Vaccine Revenue by Region: 2026-2031
3.4 North America Blister-free Syringe Vaccine Market Facts & Figures by Country
3.4.1 North America Blister-free Syringe Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Blister-free Syringe Vaccine Sales by Country (2020-2031)
3.4.3 North America Blister-free Syringe Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Blister-free Syringe Vaccine Market Facts & Figures by Country
3.5.1 Europe Blister-free Syringe Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Blister-free Syringe Vaccine Sales by Country (2020-2031)
3.5.3 Europe Blister-free Syringe Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blister-free Syringe Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Blister-free Syringe Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Blister-free Syringe Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Blister-free Syringe Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Blister-free Syringe Vaccine Market Facts & Figures by Country
3.7.1 Latin America Blister-free Syringe Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Blister-free Syringe Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Blister-free Syringe Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Blister-free Syringe Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Blister-free Syringe Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Blister-free Syringe Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Blister-free Syringe Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blister-free Syringe Vaccine Sales by Type (2020-2031)
4.1.1 Global Blister-free Syringe Vaccine Sales by Type (2020-2025)
4.1.2 Global Blister-free Syringe Vaccine Sales by Type (2026-2031)
4.1.3 Global Blister-free Syringe Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Blister-free Syringe Vaccine Revenue by Type (2020-2031)
4.2.1 Global Blister-free Syringe Vaccine Revenue by Type (2020-2025)
4.2.2 Global Blister-free Syringe Vaccine Revenue by Type (2026-2031)
4.2.3 Global Blister-free Syringe Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Blister-free Syringe Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Blister-free Syringe Vaccine Sales by Application (2020-2031)
5.1.1 Global Blister-free Syringe Vaccine Sales by Application (2020-2025)
5.1.2 Global Blister-free Syringe Vaccine Sales by Application (2026-2031)
5.1.3 Global Blister-free Syringe Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Blister-free Syringe Vaccine Revenue by Application (2020-2031)
5.2.1 Global Blister-free Syringe Vaccine Revenue by Application (2020-2025)
5.2.2 Global Blister-free Syringe Vaccine Revenue by Application (2026-2031)
5.2.3 Global Blister-free Syringe Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Blister-free Syringe Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Blister-free Syringe Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Blister-free Syringe Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Company Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Blister-free Syringe Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GSK Blister-free Syringe Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Blister-free Syringe Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Blister-free Syringe Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 CSL
6.4.1 CSL Company Information
6.4.2 CSL Description and Business Overview
6.4.3 CSL Blister-free Syringe Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CSL Blister-free Syringe Vaccine Product Portfolio
6.4.5 CSL Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Blister-free Syringe Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Blister-free Syringe Vaccine Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 KM Biologics
6.6.1 KM Biologics Company Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Blister-free Syringe Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 KM Biologics Blister-free Syringe Vaccine Product Portfolio
6.6.5 KM Biologics Recent Developments/Updates
6.7 Viatris
6.7.1 Viatris Company Information
6.7.2 Viatris Description and Business Overview
6.7.3 Viatris Blister-free Syringe Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Viatris Blister-free Syringe Vaccine Product Portfolio
6.7.5 Viatris Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Company Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Blister-free Syringe Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AstraZeneca Blister-free Syringe Vaccine Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Hualan Bio
6.9.1 Hualan Bio Company Information
6.9.2 Hualan Bio Description and Business Overview
6.9.3 Hualan Bio Blister-free Syringe Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hualan Bio Blister-free Syringe Vaccine Product Portfolio
6.9.5 Hualan Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blister-free Syringe Vaccine Industry Chain Analysis
7.2 Blister-free Syringe Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blister-free Syringe Vaccine Production Mode & Process Analysis
7.4 Blister-free Syringe Vaccine Sales and Marketing
7.4.1 Blister-free Syringe Vaccine Sales Channels
7.4.2 Blister-free Syringe Vaccine Distributors
7.5 Blister-free Syringe Vaccine Customer Analysis
8 Blister-free Syringe Vaccine Market Dynamics
8.1 Blister-free Syringe Vaccine Industry Trends
8.2 Blister-free Syringe Vaccine Market Drivers
8.3 Blister-free Syringe Vaccine Market Challenges
8.4 Blister-free Syringe Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Blister-free Syringe Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Blister-free Syringe Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Blister-free Syringe Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Blister-free Syringe Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Blister-free Syringe Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Blister-free Syringe Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Blister-free Syringe Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Blister-free Syringe Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Blister-free Syringe Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Blister-free Syringe Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Blister-free Syringe Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Blister-free Syringe Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Blister-free Syringe Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blister-free Syringe Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Blister-free Syringe Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Blister-free Syringe Vaccine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Blister-free Syringe Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Blister-free Syringe Vaccine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Blister-free Syringe Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Blister-free Syringe Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Blister-free Syringe Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Blister-free Syringe Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Blister-free Syringe Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Blister-free Syringe Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Blister-free Syringe Vaccine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Blister-free Syringe Vaccine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Blister-free Syringe Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Blister-free Syringe Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Blister-free Syringe Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Blister-free Syringe Vaccine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Blister-free Syringe Vaccine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Blister-free Syringe Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Blister-free Syringe Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Blister-free Syringe Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Blister-free Syringe Vaccine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Blister-free Syringe Vaccine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Blister-free Syringe Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Blister-free Syringe Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Blister-free Syringe Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Blister-free Syringe Vaccine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Blister-free Syringe Vaccine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Blister-free Syringe Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Blister-free Syringe Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Blister-free Syringe Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Blister-free Syringe Vaccine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Blister-free Syringe Vaccine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Blister-free Syringe Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Blister-free Syringe Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Blister-free Syringe Vaccine Sales (K Units) by Type (2020-2025)
 Table 51. Global Blister-free Syringe Vaccine Sales (K Units) by Type (2026-2031)
 Table 52. Global Blister-free Syringe Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Blister-free Syringe Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Blister-free Syringe Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Blister-free Syringe Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Blister-free Syringe Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Blister-free Syringe Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Blister-free Syringe Vaccine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Blister-free Syringe Vaccine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Blister-free Syringe Vaccine Sales (K Units) by Application (2020-2025)
 Table 61. Global Blister-free Syringe Vaccine Sales (K Units) by Application (2026-2031)
 Table 62. Global Blister-free Syringe Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Blister-free Syringe Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Blister-free Syringe Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Blister-free Syringe Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Blister-free Syringe Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Blister-free Syringe Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Blister-free Syringe Vaccine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Blister-free Syringe Vaccine Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Blister-free Syringe Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Blister-free Syringe Vaccine Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. GSK Company Information
 Table 76. GSK Description and Business Overview
 Table 77. GSK Blister-free Syringe Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. GSK Blister-free Syringe Vaccine Product
 Table 79. GSK Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Blister-free Syringe Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Blister-free Syringe Vaccine Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. CSL Company Information
 Table 86. CSL Description and Business Overview
 Table 87. CSL Blister-free Syringe Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. CSL Blister-free Syringe Vaccine Product
 Table 89. CSL Recent Developments/Updates
 Table 90. Merck Company Information
 Table 91. Merck Description and Business Overview
 Table 92. Merck Blister-free Syringe Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Merck Blister-free Syringe Vaccine Product
 Table 94. Merck Recent Developments/Updates
 Table 95. KM Biologics Company Information
 Table 96. KM Biologics Description and Business Overview
 Table 97. KM Biologics Blister-free Syringe Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. KM Biologics Blister-free Syringe Vaccine Product
 Table 99. KM Biologics Recent Developments/Updates
 Table 100. Viatris Company Information
 Table 101. Viatris Description and Business Overview
 Table 102. Viatris Blister-free Syringe Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Viatris Blister-free Syringe Vaccine Product
 Table 104. Viatris Recent Developments/Updates
 Table 105. AstraZeneca Company Information
 Table 106. AstraZeneca Description and Business Overview
 Table 107. AstraZeneca Blister-free Syringe Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. AstraZeneca Blister-free Syringe Vaccine Product
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. Hualan Bio Company Information
 Table 111. Hualan Bio Description and Business Overview
 Table 112. Hualan Bio Blister-free Syringe Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hualan Bio Blister-free Syringe Vaccine Product
 Table 114. Hualan Bio Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Blister-free Syringe Vaccine Distributors List
 Table 118. Blister-free Syringe Vaccine Customers List
 Table 119. Blister-free Syringe Vaccine Market Trends
 Table 120. Blister-free Syringe Vaccine Market Drivers
 Table 121. Blister-free Syringe Vaccine Market Challenges
 Table 122. Blister-free Syringe Vaccine Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Blister-free Syringe Vaccine
 Figure 2. Global Blister-free Syringe Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Blister-free Syringe Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Live Attenuated Vaccines Product Picture
 Figure 5. Inactivated Vaccines Product Picture
 Figure 6. mRNA Vaccine Product Picture
 Figure 7. DNA Recombination Vaccine Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Blister-free Syringe Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Blister-free Syringe Vaccine Market Share by Application: 2024 & 2031
 Figure 11. Kids Injection
 Figure 12. Adults Injection
 Figure 13. Global Blister-free Syringe Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Blister-free Syringe Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Blister-free Syringe Vaccine Sales (2020-2031) & (K Units)
 Figure 16. Global Blister-free Syringe Vaccine Average Price (US$/Unit) & (2020-2031)
 Figure 17. Blister-free Syringe Vaccine Report Years Considered
 Figure 18. Blister-free Syringe Vaccine Sales Share by Manufacturers in 2024
 Figure 19. Global Blister-free Syringe Vaccine Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Blister-free Syringe Vaccine Players: Market Share by Revenue in Blister-free Syringe Vaccine in 2024
 Figure 21. Blister-free Syringe Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Blister-free Syringe Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Blister-free Syringe Vaccine Sales Market Share by Country (2020-2031)
 Figure 24. North America Blister-free Syringe Vaccine Revenue Market Share by Country (2020-2031)
 Figure 25. United States Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Blister-free Syringe Vaccine Sales Market Share by Country (2020-2031)
 Figure 28. Europe Blister-free Syringe Vaccine Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Blister-free Syringe Vaccine Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Blister-free Syringe Vaccine Revenue Market Share by Region (2020-2031)
 Figure 36. China Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Blister-free Syringe Vaccine Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Blister-free Syringe Vaccine Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Colombia Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Blister-free Syringe Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Blister-free Syringe Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Blister-free Syringe Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Blister-free Syringe Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Blister-free Syringe Vaccine by Type (2020-2031)
 Figure 56. Global Blister-free Syringe Vaccine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Blister-free Syringe Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Blister-free Syringe Vaccine by Application (2020-2031)
 Figure 59. Global Blister-free Syringe Vaccine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Blister-free Syringe Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India